
Axonis
Advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders.
Employees
Enterprise value
$460—690m
Authorizing premium user...
Advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders.